This site is intended for Healthcare professionals only.

Bristol-Myers says cancer drug combo reduces death risk


Bristol-Myers says cancer drug combo reduces death risk

Bristol-Myers Squibb said on Monday its cancer drugs, Opdivo and Yervoy, reduced the risk of the disease spreading or death in previously untreated patients with a type of lung cancer.

The combination demonstrated a higher rate of progression-free survival, compared with chemotherapy in a late-stage trial, the company said.

The results come a week after rival Merck & Co said a trial testing its blockbuster drug Keytruda as a monotherapy in previously untreated lung cancer patients was successful.

(Reporting by Manas Mishra in Bengaluru; Editing by Anil D’Silva)



Source: REUTERS
0 comment(s) on Bristol-Myers says cancer drug combo reduces death risk

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted